Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Passage Bio, Inc. (PASG) had Cash Flow from Investing Activities of $54.95M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-64.77M |
|
-- |
|
-- |
|
$70.40M |
|
$-70.40M |
|
$5.63M |
|
$-64.77M |
|
$-64.77M |
|
$-64.77M |
|
$-64.77M |
|
$-64.77M |
|
$-64.77M |
|
$-70.40M |
|
$-68.85M |
|
60.41M |
|
60.41M |
|
$-1.07 |
|
$-1.07 |
|
| Balance Sheet Financials | |
$78.81M |
|
$9.33M |
|
$23.60M |
|
$102.41M |
|
$19.36M |
|
-- |
|
$21.79M |
|
$41.15M |
|
$61.26M |
|
$61.26M |
|
$61.26M |
|
62.06M |
|
| Cash Flow Statement Financials | |
$-47.96M |
|
|
Cash Flow from Investing Activities |
$54.95M |
$8.87M |
|
$21.71M |
|
$37.57M |
|
$15.86M |
|
$5.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-47.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-105.72% |
|
-105.72% |
|
-63.24% |
|
-105.72% |
|
$0.99 |
|
$-0.79 |
|
$-0.79 |
|